H-1B Wage Lookup

Data through FY2026 Q3 (Jun 30, 2026)

Bioverativ Therapeutics, Inc.

Company profile for Bioverativ Therapeutics, Inc. covers 6 filings across the reporting window. FY2026 certified median offer: $140,889.

FY2026 certified median
$140,889
Total filings
6
FY2026 25th–75th percentile
$121,124–$151,918
Top job title
Scientist
Certified offers by fiscal year
Fiscal yearFilingsMedian25th percentile75th percentile
FY20252$102,721$101,874$103,569
FY2026 (Q1–Q3)4$140,889$121,124$151,918

FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.

Median offer by fiscal year

Certified median offer, Bioverativ Therapeutics, Inc.FY2025 $102,721; FY2026 (Q1–Q3) $140,889$0$50,000$100,000$150,000FY2025$102,721FY2026 (Q1–Q3)$140,889Certified median offer, Bioverativ Therapeutics, Inc.FY2025 $102,721; FY2026 (Q1–Q3) $140,889$0$50k$100k$150kFY2025$102,721FY2026*$140,889
Certified H-1B LCAs, $15k–$2M, DOL OFLC

Top titles

  1. Scientist2 filings
  2. Clinical Supply Chain Project Leader1 filings
  3. Integration Expert1 filings
  4. Principal Scientist, Muscle and Inflammation1 filings
  5. Senior Associate Scientist, Research1 filings

Top cities

  1. Cambridge3 filings
  2. Waltham3 filings

Employer and title details